PubRank

T Klingebiel

Author PubWeight™ 147.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 New insights to the MLL recombinome of acute leukemias. Leukemia 2009 4.07
2 Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia 2009 2.78
3 The MLL recombinome of acute leukemias in 2013. Leukemia 2013 2.55
4 Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995 2.43
5 Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. J Clin Oncol 1999 2.25
6 Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001 1.93
7 Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 1999 1.75
8 Detection of PCR-amplified fungal DNA by using a PCR-ELISA system. Med Mycol 1998 1.61
9 A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Eur J Cancer 1995 1.59
10 Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 2004 1.58
11 Cytomegalovirus monitoring by polymerase chain reaction of whole blood samples from patients undergoing autologous bone marrow or peripheral blood progenitor cell transplantation. J Infect Dis 1997 1.57
12 The MLL recombinome of acute leukemias. Leukemia 2006 1.51
13 Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001 1.50
14 Correction of persistent thrombocytopenia by a boost of CD133+ selected stem cells in a patient transplanted for Wiskott-Aldrich syndrome 10 years ago. Bone Marrow Transplant 2004 1.48
15 A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a. Cancer Immunol Immunother 1992 1.44
16 Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System. Clin Endocrinol (Oxf) 2007 1.42
17 Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group. Lancet 1995 1.42
18 Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry. J Clin Oncol 1998 1.41
19 Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. Blood 2000 1.30
20 Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Klin Padiatr 2005 1.26
21 Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection. Bone Marrow Transplant 2000 1.26
22 Prospective screening by a panfungal polymerase chain reaction assay in patients at risk for fungal infections: implications for the management of febrile neutropenia. Br J Haematol 2000 1.20
23 Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant 2012 1.18
24 Longitudinal gonadal function after bone marrow transplantation for acute lymphoblastic leukemia during childhood. Pediatr Transplant 1999 1.18
25 Scintigraphic imaging of neuroblastoma with [131-I]iodobenzylguanidine. Lancet 1984 1.12
26 Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 2002 1.11
27 Treatment of neuroblastoma with metaiodobenzylguanidine: results and side effects. Med Pediatr Oncol 1987 1.08
28 How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005 1.07
29 1070 myeloablative megatherapy procedures followed by stem cell rescue for neuroblastoma: 17 years of European experience and conclusions. European Group for Blood and Marrow Transplant Registry Solid Tumour Working Party. Eur J Cancer 1997 1.07
30 Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998 1.06
31 A prospective randomized controlled trial comparing PCR-based and empirical treatment with liposomal amphotericin B in patients after allo-SCT. Bone Marrow Transplant 2008 1.06
32 Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child. J Infect Dis 1999 1.05
33 Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group. Bone Marrow Transplant 2003 1.04
34 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures. Bone Marrow Transplant 2008 1.04
35 Leucocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients. Br J Haematol 1999 1.03
36 Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group. Klin Padiatr 1998 1.02
37 Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999 1.00
38 Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant 1998 1.00
39 Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999 0.98
40 A comparison between three graft manipulation methods for haploidentical stem cell transplantation in pediatric patients: preliminary results of a pilot study. Klin Padiatr 2005 0.98
41 Catheter-related Rahnella aquatilis bacteremia in a pediatric bone marrow transplant recipient. J Clin Microbiol 1993 0.96
42 A prospective analysis of the pattern of immune reconstitution in a paediatric cohort following transplantation of positively selected human leucocyte antigen-disparate haematopoietic stem cells from parental donors. Br J Haematol 2001 0.96
43 Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997 0.96
44 Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy. Bone Marrow Transplant 2008 0.96
45 Late effects after stem cell transplantation (SCT) in children--growth and hormones. Bone Marrow Transplant 2005 0.95
46 Immune recovery in children undergoing allogeneic stem cell transplantation: absolute CD8+ CD3+ count reconstitution is associated with survival. Bone Marrow Transplant 2007 0.94
47 Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 2004 0.94
48 Evaluation of Murex CMV DNA hybrid capture assay for detection and quantitation of cytomegalovirus infection in patients following allogeneic stem cell transplantation. J Clin Microbiol 1998 0.93
49 Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment. Leukemia 1999 0.93
50 T cells for suicide gene therapy: activation, functionality and clinical relevance. J Immunol Methods 2007 0.93
51 Common genetic variants in the interleukin-6 and chitotriosidase genes are associated with the risk for serious infection in children undergoing therapy for acute myeloid leukemia. Leukemia 2005 0.93
52 Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplant 1997 0.93
53 Transplantation of megadoses of purified haploidentical stem cells. Ann N Y Acad Sci 1999 0.92
54 Complex MLL rearrangements in t(4;11) leukemia patients with absent AF4.MLL fusion allele. Leukemia 2007 0.91
55 Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes. Gene Ther 2003 0.91
56 [Outstanding awards and honors for pediatric oncologists]. Klin Padiatr 2012 0.91
57 Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer 1997 0.90
58 Spliced MLL fusions: a novel mechanism to generate functional chimeric MLL-MLLT1 transcripts in t(11;19)(q23;p13.3) leukemia. Leukemia 2007 0.90
59 Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy. Haemophilia 2002 0.90
60 WT1 peptide-specific T cells generated from peripheral blood of healthy donors: possible implications for adoptive immunotherapy after allogeneic stem cell transplantation. Leukemia 2009 0.90
61 Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemia. Leukemia 2005 0.89
62 Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: results of the German Cooperative Study. Blood 1991 0.89
63 The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients. Ann Oncol 1996 0.89
64 Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia 2007 0.89
65 ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3- NK cells. Int J Hematol 2007 0.89
66 High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 2003 0.89
67 No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol 2011 0.88
68 Rapid development of ganciclovir-resistant cytomegalovirus infection in children after allogeneic stem cell transplantation in the early phase of immune cell recovery. Bone Marrow Transplant 2002 0.88
69 A prospective comparison of immune reconstitution in pediatric recipients of positively selected CD34+ peripheral blood stem cells from unrelated donors vs recipients of unmanipulated bone marrow from related donors. Bone Marrow Transplant 2003 0.87
70 Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients. Clin Microbiol Infect 2011 0.87
71 A contribution to the morphology and pathogenesis of thyroid-like lesions in the kidney. Pathol Res Pract 1983 0.87
72 Age-matched dendritic cell subpopulations reference values in childhood. Scand J Immunol 2013 0.86
73 Isolation and transplantation of highly purified autologous peripheral CD34(+) progenitor cells: purging efficacy, hematopoietic reconstitution and long-term outcome in children with high-risk neuroblastoma. Bone Marrow Transplant 2002 0.86
74 Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Haematol 1995 0.86
75 Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000. Klin Padiatr 2013 0.86
76 Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transplant 2012 0.85
77 Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias. Br J Cancer 1992 0.85
78 High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastoma. Med Pediatr Oncol 1994 0.84
79 Impact of megatherapy on survival after relapse from stage 4 neuroblastoma in patients over 1 year of age at diagnosis: a report from the European Group for Bone Marrow Transplantation. J Clin Oncol 1993 0.84
80 Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis. Bone Marrow Transplant 2009 0.84
81 Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia 1996 0.84
82 Clinical relevance of serial quantitative analysis of hematopoietic chimerism after allogeneic stem cell transplantation in children for severe aplastic anemia. Bone Marrow Transplant 2004 0.83
83 Pheochromocytoma in childhood: implication for further diagnostic procedures. Acta Paediatr 2004 0.83
84 Treatment of acute graft-versus-host disease with PUVA (psoralen and ultraviolet irradiation): results of a pilot study. Bone Marrow Transplant 1999 0.83
85 Comparison of auto versus allografting as consolidation of primary treatments in advanced neuroblastoma over one year of age at diagnosis: report from the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994 0.83
86 Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia 2003 0.83
87 Metaiodobenzylguanidine (MIBG) labeled with 123I/131I in neuroblastoma diagnosis and follow-up treatment with a review of the diagnostic results of the International Workshop of Pediatric Oncology held in Rome, September 1986. Med Pediatr Oncol 1987 0.83
88 Autologous transplantation of CD133 selected hematopoietic progenitor cells in a pediatric patient with relapsed leukemia. Bone Marrow Transplant 2002 0.82
89 Noncutaneous varicella-zoster virus (VZV) infection with fatal liver failure in a child with acute lymphoblastic leukemia (ALL). Med Pediatr Oncol 2001 0.82
90 Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Prolif 2008 0.82
91 Statement of current majority practices in graft-versus-host disease prophylaxis and treatment in children. Bone Marrow Transplant 2000 0.82
92 High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2002 0.82
93 Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children. Bone Marrow Transplant 1999 0.82
94 Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br J Haematol 2000 0.82
95 Allogeneic stem cell transplantation for pediatric and adolescent patients with CML: results from the prospective trial CML-paed I. Klin Padiatr 2009 0.82
96 Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group. Klin Padiatr 2008 0.82
97 Hepatic veno-occlusive disease in pediatric stem cell recipients: successful treatment with continuous infusion of prostaglandin E1 and low-dose heparin. Ann Hematol 1998 0.81
98 Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients. Mycoses 1997 0.81
99 Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: an update. Klin Padiatr 2005 0.81
100 Feasibility of IL-15-activated cytokine-induced killer cell infusions after haploidentical stem cell transplantation. Bone Marrow Transplant 2013 0.81
101 Multivariate analyses of immune reconstitution in children after allo-SCT: risk-estimation based on age-matched leukocyte sub-populations. Bone Marrow Transplant 2009 0.80
102 Monitoring of post-transplant remission of childhood malignancies: is there a standard? Bone Marrow Transplant 2008 0.80
103 Prospective comparison of PCR-based vs late mRNA-based preemptive antiviral therapy for HCMV infection in patients after allo-SCT. Bone Marrow Transplant 2010 0.80
104 Allogeneic haematopoietic stem cell transplantation in children with acute lymphoblastic leukaemia: the BFM/IBFM/EBMT concepts. Bone Marrow Transplant 2005 0.80
105 Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma. J Hematother 1997 0.80
106 Expression analysis of multidrug resistance associated genes in neuroblastomas. Oncol Rep 1999 0.80
107 Risk of angioedema following invasive or surgical procedures in HAE type I and II--the natural history. Allergy 2013 0.80
108 Morphometric studies on acute renal failure in humans during the oligoanuric and polyuric phases. Clin Nephrol 1983 0.79
109 Intestinal acute graft-versus-host disease: findings on sonography. AJR Am J Roentgenol 2000 0.79
110 Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. Anticancer Res 1996 0.79
111 Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 2001 0.79
112 [High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS]. Klin Padiatr 1999 0.79
113 CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation. Cytotherapy 2006 0.79
114 Does megatherapy contribute to survival in metastatic neuroblastoma? A retrospective analysis. German Cooperative Neuroblastoma Study Group. Klin Padiatr 1997 0.78
115 Detection of neuroblastoma cells during clinical follow up: advanced flow cytometry and rt-PCR for tyrosine hydroxylase using both conventional and real-time PCR. Klin Padiatr 2011 0.78
116 Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse? Bone Marrow Transplant 1997 0.78
117 German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells. Bone Marrow Transplant 1997 0.78
118 Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy. AIDS 2001 0.78
119 [EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results]. Klin Padiatr 1999 0.78
120 Stem cell transplantation. Klin Padiatr 2013 0.78
121 Transplantation activities and treatment strategies in paediatric stem cell transplantation centres: a report from the EBMT Working Party on Paediatric Diseases. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998 0.78
122 [Regional hyperthermia with systemic chemotherapy in children and adolescents: feasibility and clinical follow-up of 34 intensively pretreated patients with prognostically unfavorable tumor diseases]. Klin Padiatr 1993 0.78
123 Which children do benefit from bone marrow transplant? The EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 1996 0.78
124 Stability and pharmacokinetics of m-[131I]iodobenzylguanidine in patients. Cancer Res 1987 0.77
125 Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996 0.77
126 Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation. Bone Marrow Transplant 2002 0.77
127 Aggressive combination chemotherapy of bone marrow relapse in childhood acute lymphoblastic leukemia containing aclacinomycin-A: a multicentric trial. Haematol Blood Transfus 1987 0.77
128 [Prognosis of children with chronic myeloid leukemia: a retrospective analysis of 75 patients]. Klin Padiatr 1996 0.77
129 Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news? Br J Cancer 2003 0.77
130 The state of research into children with cancer across Europe: new policies for a new decade. Ecancermedicalscience 2011 0.77
131 Orointestinal yeast colonization of paediatric bone marrow transplant recipients: surveillance by quantitative culture and serology. Mycoses 1995 0.77
132 Intensive chemotherapy versus bone marrow transplantation in pediatric acute myeloid leukemia: a matter of controversies. Blood 2001 0.77
133 Quantification of chimerism within peripheral blood, bone marrow and purified leukocyte subsets: comparison of singleplex and multiplex PCR amplification of short tandem repeat (STR) loci. Eur J Haematol 2006 0.77
134 Functional analysis of P-glycoprotein and multidrug resistance associated protein related multidrug resistance in AML-blasts. Leuk Res 1999 0.77
135 Role and perspectives of BMT in ALL: the BFM experience. Bone Marrow Transplant 1991 0.77
136 Transplantation of highly purified peripheral-blood CD34+ progenitor cells from related and unrelated donors in children with nonmalignant diseases. Bone Marrow Transplant 2004 0.76
137 Creatinine clearance and renal interstitium in diffuse endocapillary proliferative glomerulonephritis. Pathol Res Pract 1985 0.76
138 No effect of antifungal compounds on functional properties of human antifungal T-helper type 1 cells. Transpl Infect Dis 2013 0.76
139 Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr 2012 0.76
140 [Relapse of childhood ALL, AML and MDS after allogeneic stem cell transplantation can be prevented by donor lymphocyte infusion in a critical stage of increasing mixed chimerism]. Klin Padiatr 2002 0.76
141 Isolated extramedullary relapse in children with acute lymphoblastic leukemia: a comparison between treatment results of chemotherapy and bone marrow transplantation. BFM Relapse Study Group. Bone Marrow Transplant 1995 0.76
142 Clinical experiences in the treatment of neuroblastoma with 131I-metaiodobenzylguanidine. Pediatr Hematol Oncol 1986 0.76
143 Intraspinal high-grade astrocytoma in a child--rationale for chemotherapy and more intensive radiotherapy? Childs Nerv Syst 1997 0.76
144 Myeloid and plasmacytoid dendritic cells: reference ranges in the peripheral blood of healthy children. Klin Padiatr 2013 0.76
145 Immunoglobulin and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic leukemia after stem cell transplantation. Leukemia 2009 0.76
146 Extramedullary relapses at uncommon sites after allogeneic stem cell transplantation. Bone Marrow Transplant 2000 0.76
147 [Juvenile chronic leukemia and chronic myelomonocytic leukemia. Experiences with bone marrow transplantation in childhood in 5 cases]. Monatsschr Kinderheilkd 1992 0.76
148 Retrochorionic hematoma in congenital afibrinogenemia: resolution with fibrinogen concentrate infusions. Am J Hematol 2007 0.76
149 Immunological aspects of haploidentical stem cell transplantation in children. Ann N Y Acad Sci 2001 0.76
150 Transplantation of CD34+ enriched allografts in children with nonmalignant diseases: does graft manipulation necessarily result in high incidence of graft failure? Bone Marrow Transplant 2004 0.75
151 Diagnostic approaches for immunocompromised paediatric patients with pulmonary infiltrates. Clin Microbiol Infect 2006 0.75
152 Selection of Candida glabrata in pediatric bone marrow transplant recipients receiving fluconazole. Pediatr Hematol Oncol 1994 0.75
153 Parvovirus B19 pneumonia in a child undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007 0.75
154 Immunity against tetanus and diphtheria after childhood sarcoma treatment. Klin Padiatr 2010 0.75
155 [Technical aspects of autologous bone marrow transplantation]. Infusionsther Transfusionsmed 1994 0.75
156 Psychosocial care in children with stem cell transplantation. Bone Marrow Transplant 2001 0.75
157 [Current state of cord blood transplantation in childhood]. Klin Padiatr 2002 0.75
158 Remission of a lymphoproliferative disorder occurring after second BMT from an unrelated donor in a 5-year-old boy with severe aplastic anemia. Bone Marrow Transplant 1995 0.75
159 PAX2 is an antiapoptotic molecule with deregulated expression in medulloblastoma. Int J Oncol 2012 0.75
160 Impact of minimal residual disease detection prior to autologous stem cell transplantation for post-transplant outcome in high risk neuroblastoma. Klin Padiatr 2012 0.75
161 Peripheral stem cell collection and transplantation in pediatric patients. Prog Clin Biol Res 1992 0.75
162 Bone marrow transplantation in children with neuroblastoma. Folia Haematol Int Mag Klin Morphol Blutforsch 1989 0.75
163 Emotional adaptation of children undergoing bone marrow transplantation. Can J Psychiatry 1999 0.75
164 Differential diagnosis of metastases in bone scans: chemotherapy induced bone necrosis. Nuklearmedizin 1999 0.75
165 [Bone marrow transplantation in acute leukemia, chronic myeloid leukemia, severe aplastic anemia and stage IV neuroblastoma. Effect of antiviral prevention with anti-CMV-hyperimmunoglobulin and acyclovir]. Klin Wochenschr 1986 0.75
166 Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 1996 0.75
167 Application of the murine anti-Gd-2 antibody 14.Gd-2a for diagnosis and therapy of neuroblastoma. Int J Rad Appl Instrum B 1991 0.75
168 [Sonography of the larynx in children. New perspectives due to the use of computerized sonography: 2: Sonographic findings in a case of laryngeal papillomatosis]. Klin Padiatr 1989 0.75
169 [Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]. Dtsch Med Wochenschr 2001 0.75
170 Response of children with stage IV soft tissue sarcoma to topotecan and carboplatin: a phase II window trial of the cooperative soft tissue sarcoma group. Klin Padiatr 2013 0.75
171 Actual role and perspectives of BMT in children. Bone Marrow Transplant 1989 0.75
172 [Kind-Philipp Symposium in honor to the trustor Dr.-Ing. Walter Reiners and Kind-Philipp Award 2008]. Klin Padiatr 2009 0.75
173 Effect of amifostine on neuroblastoma during high dose chemotherapy: in vivo and in vitro investigations. Anticancer Res 2001 0.75
174 [Milestones of health policy and rare diseases]. Klin Padiatr 2010 0.75
175 Acute renal failure--an integrative discussion of morphologic and functional findings. Klin Wochenschr 1982 0.75
176 Case report 756: Chronic multifocal osteomyelitis. Skeletal Radiol 1992 0.75
177 [Experience with the G-DRG-system five years after its introduction, as assessed by the Society of Pediatric Oncology and Hematology (GPOH)]. Klin Padiatr 2007 0.75
178 Transplant activities in Germany in 1998--a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation. Ann Hematol 2000 0.75
179 [On the 80th birthday of Prof. Riehm]. Klin Padiatr 2013 0.75
180 [Differential diagnosis of childhood osteomyelitis--classification according to scintigraphic, radiologic and magnetic resonance tomographic characteristics]. Nuklearmedizin 1996 0.75
181 [Radiation absorption and proton relaxation times of the liver in vitro following carbon tetrachloride poisoning]. Digitale Bilddiagn 1987 0.75
182 Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors. Prog Clin Biol Res 1994 0.75
183 [Bone marrow transplantation in leukemias in the absence of HLA-identical siblings--results of the 4th meeting of experts of the Kind-Philipp Foundation at Reisenburg 11/12 November 1985]. Klin Padiatr 1986 0.75
184 [Requirements and performance profile of the Paediatric Radiation Oncology Working Group (APRO): evaluation of the present situation and description of future developments]. Klin Padiatr 2007 0.75
185 [Adolescents with cancer - administrative, clinical and scientific implications]. Klin Padiatr 2011 0.75
186 MIBG-treatment in neuroblastoma; experiences of the Tübingen/Frankfurt group. Prog Clin Biol Res 1988 0.75
187 [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine]. Klin Padiatr 1986 0.75
188 [131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma]. Klin Padiatr 1989 0.75
189 [Occurrence of acute kidney failure in endocapillary glomerulonephritis of the poststreptococcal glomerulonephritis type]. Pathologe 1985 0.75
190 10-Parameter flow cytometry as a new tool to improve diagnosis and MRD follow-up of acute leukemias. Klin Padiatr 2009 0.75
191 [Comparison of chemotherapy alone with allogeneic bone marrow transplantation in first full remission in children with acute myeloid leukemia in the AML-BFM-83 and AML-BFM-87 studies--matched pair analysis]. Klin Padiatr 1992 0.75
192 OKT-3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants. Br J Haematol 2000 0.75
193 Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis. Haematologica 2000 0.75
194 [Diagnostic difficulties in encephalitis and glioma]. Klin Padiatr 2006 0.75
195 [Supporting research in pediatric oncology and hematology]. Klin Padiatr 2007 0.75
196 Radiolabeled metaiodobenzylguanidine (mibg) in diagnosis and therapy of neuroblastoma - results from basic research (review). Int J Oncol 1995 0.75
197 [Treatment of chronic myeloid leukemia in children and adolescents--concept of the multicenter pilot study CML-ped]. Klin Padiatr 1996 0.75
198 Monitoring of donor cell chimerism for the detection of relapse and early immunotherapeutic intervention in acute lymphoblastic leukemias. Ann Hematol 2002 0.75
199 Survival following disease recurrence of primary localized alveolar rhabdomyosarcoma. Pediatr Blood Cancer 2013 0.75
200 Costal BCG osteomyelitis presenting as a tumor. Infection 1992 0.75
201 [Phases in disease and therapy. An attempt at understanding]. Pflege Z 1994 0.75
202 [Ultrasound diagnosis of the larynx with the aid of computerized sonography]. Laryngorhinootologie 1989 0.75
203 Allogeneic bone marrow transplantation in childhood leukemia: results and strategies in the Federal Republic of Germany. Haematol Blood Transfus 1990 0.75
204 Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients. Bone Marrow Transplant 2005 0.75
205 [20 years of German-Russian cooperation in pediatric hematology and oncology]. Klin Padiatr 2011 0.75
206 [Treatment of children and adolecents with cancer after the application of the guide lines for good clinical practice in 2004 and the evaluation of new measurements]. Klin Padiatr 2012 0.75
207 Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93. Eur J Clin Microbiol Infect Dis 2007 0.75
208 [Experimental hematology and clinical immunology]. Klin Padiatr 2008 0.75
209 Survey of supportive care standards for paediatric allogeneic stem cell transplantation patients in Europe: a first report from the EBMT Paediatric Diseases Working Party. Bone Marrow Transplant 1996 0.75
210 The challenge of pooling national registries in pediatric bone marrow transplantation. Bone Marrow Transplant 1996 0.75
211 Meningitis due to multiple-resistant penicillin- and cefotaxime-intermediate Streptococcus pneumoniae in a German child after bone marrow transplantation. Infection 2003 0.75
212 Proposal for standard recommendations for prophylaxis of graft-versus-host disease in children. European Group for Blood and Marrow Transplantation (EBMT) Working Party Paediatric Diseases and the International Study Committee of the BFM family-subcommittee Bone Marrow Transplantation (IBFM-STG). Bone Marrow Transplant 1998 0.75
213 Prospective study on allogeneic bone marrow transplantation (allo BMT) versus chemotherapy (chemo) for very high-risk (VHR) childhood acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant 2001 0.75
214 Effects of catecholestrogens on luteinizing hormone levels in long tem ovariectomized adult rats. Endocrinology 1981 0.75
215 Isotachophoretic determination of phosphate splitting from Amifostine and p-nitrophenyl phosphate in serum and neuroblastoma cells. J Chromatogr A 1999 0.75
216 Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia. Semin Hematol 1993 0.75
217 [Bone marrow transplantation in chronic myeloid leukemia. Influence of gnotobiotic measures, especially antiviral prophylaxis]. Dtsch Med Wochenschr 1986 0.75
218 [Thrombocyte substitution in children under cytostatic therapy]. Beitr Infusionther Klin Ernahr 1986 0.75
219 Aneurysmal bone cyst in early childhood. Ultrasound findings. Pediatr Radiol 1993 0.75
220 [Networking in pediatrics and the journal's view]. Klin Padiatr 2009 0.75